Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Potassium chloride + magnesium chloride + sodium acetate + sodium chloride + sodium gluconate** is a balanced, isotonic crystalloid intravenous electrolyte solution. The input name is truncated at \"sodium\" and is interpreted as sodium gluconate based on the corresponding marketed formulations. These products provide sodium, potassium, magnesium, chloride, acetate, and gluconate to restore extracellular fluid volume and electrolyte balance; acetate and gluconate are metabolizable anions that exert an alkalinizing effect. Representative products include Plasma-Lyte A, Normosol-R, Isolyte S, and generic Multiple Electrolytes Injection, Type 1 formulations. They are used for replacement of acute extracellular fluid losses, including in surgery, trauma, burns, moderate blood loss, and shock.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + magnesium chloride + sodium acetate + sodium chloride + sodium gluconate.